Efficient fdCas9 Synthetic Endonuclease with Improved Specificity for Precise Genome Engineering
Author(s) -
Mustapha Aouida,
Ayman Eid,
Zahir Ali,
Thomas J. Cradick,
Ciaran M. Lee,
Harshavardhan Deshmukh,
Ahmed Atef,
Dina B. AbuSamra,
Samah Zeineb Gadhoum,
Jasmeen S. Merzaban,
Gang Bao,
Magdy M. Mahfouz
Publication year - 2015
Publication title -
plos one
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.99
H-Index - 332
ISSN - 1932-6203
DOI - 10.1371/journal.pone.0133373
Subject(s) - endonuclease , genome editing , genome engineering , cas9 , crispr , genome , computational biology , biology , protein engineering , restriction enzyme , genetics , dna , enzyme , gene , biochemistry
The Cas9 endonuclease is used for genome editing applications in diverse eukaryotic species. A high frequency of off-target activity has been reported in many cell types, limiting its applications to genome engineering, especially in genomic medicine. Here, we generated a synthetic chimeric protein between the catalytic domain of the FokI endonuclease and the catalytically inactive Cas9 protein (fdCas9). A pair of guide RNAs (gRNAs) that bind to sense and antisense strands with a defined spacer sequence range can be used to form a catalytically active dimeric fdCas9 protein and generate double-strand breaks (DSBs) within the spacer sequence. Our data demonstrate an improved catalytic activity of the fdCas9 endonuclease, with a spacer range of 15–39 nucleotides, on surrogate reporters and genomic targets. Furthermore, we observed no detectable fdCas9 activity at known Cas9 off-target sites. Taken together, our data suggest that the fdCas9 endonuclease variant is a superior platform for genome editing applications in eukaryotic systems including mammalian cells.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom